Search for: "Medicis Pharmaceutical Corp." Results 41 - 60 of 60
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy': (IP… [read post]
5 Feb 2016, 7:53 am
Medicis Pharmaceutical Corp., No. cv-15-0065-PR, 2016 WL 237777 (Ariz. [read post]
3 Mar 2016, 5:19 am
Medicis Pharmaceutical Corp., ___ P.3d ___, 2016 WL 237777, at *5 (Ariz. [read post]
10 Aug 2011, 4:30 am by Marie Louise
  Highlights this week included: Argatroban (Argipidine) – US – Federal Circuit affirms validity of Argatroban patent, Japanese translation issue: Mitsubishi Chemical Corp. v. [read post]
18 Jul 2014, 11:55 am
Wyeth Pharmaceuticals, Inc., 2008 WL 7136137 (Ala. [read post]
9 Apr 2015, 5:00 am
Medicis Pharmaceutical Corp., 342 P.3d 847 (Ariz App. 2015), once, here. [read post]
29 Jan 2014, 3:13 am by Dennis Crouch
Medicis Pharmaceutical Corp., 537 F.3d 1329 (Fed. [read post]
28 Mar 2008, 6:00 am
- Anonymity of policy research group quoted on pharma patenting policy and stats: (Spicy IP),Thailand: More news/reactions on compulsory licenses: (Generic Pharmaceuticals & IP),US: Follow-on biologic drugs and patent law: A potential disconnect? [read post]
6 Jun 2008, 6:49 am
: (Spicy IP)   Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP)   Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt)     Events 26 August:… [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46)   Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]
29 Aug 2008, 1:25 pm
: (IP finance), Facebook removes international access to Scrabulous, except from India: (Ars Technica), (Techdirt), Reverse engineering can resolve conflict between standardisation and competition: (Techdirt), Benefits of piracy aren’t always in the expected places: (Techdirt)   Events 1-3 September: Federation of Indian Chambers of Commerce and Industry, Department of Industrial Property and Promotion, and WIPO conference on ‘Development and IP: Building synergies… [read post]
18 Apr 2008, 2:00 am
: RealNetworks, Mattel and Hasbro copy the infringer by creating online Scrabble: (IP ThinkTank), Creative Commons Statement of Intent for Attribution-Share Alike Licenses released: (creativecommons.org) Events IP Business Congress – 25-26 June, Amsterdam: (IP Business Congress), INTA annual meeting – 17-21 May, Berlin: (IMPACT), Australia: IPRIA / CELRL / IP Australia: Employees’ IP and the employment relationship – incentives to innovate… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva Pharma USA… [read post]